Download Poster (606.62 KB)

Symposium
  • PReS •
  • 17 September, 2026 •
  • •

Unlocking HLH/MAS: From Clinical Recognition to Optimized Management Using Biomarkers

Fabrizio De Benedetti, Claudia Bracaglia, Christoph Kessel

Available materials

Video
Publication
  • PReS •
  • 17 September, 2026 •
  • •

Updated Population Pharmacokinetic/Pharmacodynamic Analysis of Emapalumab in Patients With Macrophage Activation Syndrome (MAS) Associated With Still’s Disease and Systemic Lupus Erythematosus (SLE)

Patrick Brossard, Axel Facius, Brian Jamieson

Available materials

Poster
Publication
  • EULAR •
  • 5 June, 2026 •
  • •

Updated exposure–safety analysis of emapalumab in patients with macrophage activation syndrome (MAS)

Rafael Krmar, Brian Jamieson, Fabrizio De Benedetti, Alexei A. Grom, Axel Facius, Patrick Brossard

Available materials

Poster
Publication
  • EULAR •
  • 5 June, 2026 •
  • •

Updated population pharmacokinetic (popPK) model for emapalumab using data from four prospective clinical trials in patients with hemophagocytic lymphohistiocytosis/macrophage activation syndrome (MAS)

Patrick Brossard, Axel Facius, Brian Jamieson

Available materials

Poster
Sign up for alerts